American International Group Inc. Sells 9,618 Shares of Genpact Limited (NYSE:G)

American International Group Inc. decreased its position in Genpact Limited (NYSE:GFree Report) by 4.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 225,909 shares of the business services provider’s stock after selling 9,618 shares during the quarter. American International Group Inc. owned 0.12% of Genpact worth $7,841,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also added to or reduced their stakes in G. HighTower Advisors LLC increased its position in shares of Genpact by 4.5% during the 3rd quarter. HighTower Advisors LLC now owns 10,939 shares of the business services provider’s stock valued at $402,000 after purchasing an additional 467 shares during the last quarter. Paralel Advisors LLC increased its position in shares of Genpact by 1.3% during the 3rd quarter. Paralel Advisors LLC now owns 41,425 shares of the business services provider’s stock valued at $1,500,000 after purchasing an additional 517 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Genpact by 44.5% during the 3rd quarter. PNC Financial Services Group Inc. now owns 8,076 shares of the business services provider’s stock valued at $292,000 after purchasing an additional 2,488 shares during the last quarter. Envestnet Portfolio Solutions Inc. bought a new position in shares of Genpact during the 3rd quarter valued at approximately $266,000. Finally, Envestnet Asset Management Inc. increased its position in shares of Genpact by 76.9% during the 3rd quarter. Envestnet Asset Management Inc. now owns 492,762 shares of the business services provider’s stock valued at $17,838,000 after purchasing an additional 214,140 shares during the last quarter. Institutional investors own 96.03% of the company’s stock.

Genpact Trading Down 0.3 %

NYSE G opened at $31.05 on Thursday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.54 and a current ratio of 1.54. The company has a market capitalization of $5.59 billion, a price-to-earnings ratio of 8.87, a price-to-earnings-growth ratio of 1.46 and a beta of 1.12. The company’s 50-day simple moving average is $32.34 and its two-hundred day simple moving average is $33.72. Genpact Limited has a one year low of $29.41 and a one year high of $39.58.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings data on Thursday, May 9th. The business services provider reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.06. Genpact had a net margin of 14.21% and a return on equity of 22.71%. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.11 billion. Equities analysts forecast that Genpact Limited will post 2.7 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 26th. Investors of record on Monday, June 10th will be paid a $0.153 dividend. This represents a $0.61 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Monday, June 10th. Genpact’s dividend payout ratio (DPR) is presently 17.43%.

Insider Buying and Selling

In related news, Director N. V. Tyagarajan sold 1,000 shares of Genpact stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $33.17, for a total value of $33,170.00. Following the completion of the sale, the director now directly owns 7,300 shares in the company, valued at approximately $242,141. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.80% of the stock is owned by company insiders.

Analysts Set New Price Targets

G has been the topic of several analyst reports. Needham & Company LLC reissued a “buy” rating and set a $40.00 target price on shares of Genpact in a research report on Friday, May 10th. Citigroup lowered their target price on shares of Genpact from $36.00 to $33.00 and set a “neutral” rating for the company in a research note on Monday, April 22nd. StockNews.com lowered shares of Genpact from a “strong-buy” rating to a “buy” rating in a report on Friday, April 5th. BMO Capital Markets decreased their price objective on shares of Genpact from $39.00 to $38.00 and set a “market perform” rating for the company in a report on Friday, May 10th. Finally, Wedbush reiterated a “neutral” rating and set a $35.00 price objective on shares of Genpact in a report on Friday, May 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Genpact has an average rating of “Hold” and an average price target of $38.00.

Get Our Latest Stock Report on Genpact

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.